Telemedicine support for people considering living kidney donation
Official title: Telemedicine for Evaluation and Counseling of Living Kidney Donor Candidates
Run by University of California, Irvine · NCT07206069 · Data updated 2026-11-12
This trial tests whether telemedicine video visits can help adults in California who are registered living kidney donor candidates get education, counseling, and support compared with standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of California, Irvine Academic / other |
| Locations | 1 site (Orange, California) |
| Status | Recruiting |
| Started | May 4, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07206069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (18+) who reside in California and are registered living kidney donor candidates at UC Irvine without medical contraindications to donation.
✕Probably not a fit
People with medical contraindications to donation, those living outside California or not registered at UC Irvine, or those without reliable internet/video access are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized pilot feasibility trial at UC Irvine compares standard care with a telemedicine care coordination approach for registered living kidney donor candidates. Participants are randomly assigned to either a control arm (recorded video education plus an in-person donor evaluation and counseling) or an intervention arm (two live telemedicine video sessions for education and for donor evaluation/counseling). The study will measure practicality, acceptability, and whether telemedicine shared decision-making improves candidate engagement and decision-making during the evaluation process. Findings will provide preliminary data to guide wider use of telemedicine in living donor evaluation.
Why it matters
Potential benefit: If successful, telemedicine could make donor education and counseling easier to access, reduce travel and logistical barriers, and improve donor decision-making and engagement.
How similar studies have gone: Telemedicine has shown promise in transplant and remote care settings, but using telemedicine specifically for shared decision-making in living donor evaluation is not well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Reside in the State of California * Registered living kidney donor candidate at UC Irvine Medical Center Exclusion Criteria: \- Individuals with a contraindication to living kidney donation (for example, heart disease, cancer)
Where it's running
-
University of California Irvine Medical Center
Orange, California, United States Recruiting
Study contacts
- Principal investigator: Fawaz Al Ammary, MD PhD — University of California, Irvine
- Study coordinator: Fawaz Al Ammary, MD PhD
- Email: fawaz.alammary@uci.edu
- Phone: 657-223-4966
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the impact of perinephric fat thickness on kidney function after donation
This study is testing if the thickness of fat around the kidneys affects kidney function and blood pressure in people who are donating a kidney.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.